Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
You've probably heard about the gene-editing technology CRISPR. The massive biotech breakthrough, which has emerged in the last decade, has mainly been touted for the ways it will let scientists edit ...
CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback